Published in Biomed Microdevices on August 01, 2016
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). Anal Chem (1998) 15.53
Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature (2012) 10.39
Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J Clin Invest (2002) 4.64
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res (2005) 4.33
A passive pumping method for microfluidic devices. Lab Chip (2002) 3.87
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol (2006) 2.67
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis (2004) 2.35
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci U S A (2012) 2.29
Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res (2012) 2.20
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep (2012) 2.20
Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol (2008) 2.08
Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer (1995) 2.05
Three-dimensional in vitro tissue culture models of breast cancer-- a review. Breast Cancer Res Treat (2004) 1.88
The tumor microenvironment at a glance. J Cell Sci (2012) 1.79
Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip (2013) 1.64
Human breast carcinoma desmoplasia is PDGF initiated. Oncogene (2000) 1.59
Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. PLoS One (2011) 1.37
A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials (2013) 1.34
Cellular observations enabled by microculture: paracrine signaling and population demographics. Integr Biol (Camb) (2009) 1.33
Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta (2010) 1.32
3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev (2014) 1.30
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production. Cell Cycle (2012) 1.29
The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer (2014) 1.27
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol (2013) 1.26
The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev (2014) 1.25
Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol Int (2001) 1.20
Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts. Int J Cancer (2009) 1.19
Microfluidic platform for chemotaxis in gradients formed by CXCL12 source-sink cells. Integr Biol (Camb) (2010) 1.17
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis (2005) 1.16
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation. Proc Natl Acad Sci U S A (2014) 1.13
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer. Oncogene (2013) 1.12
Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer (1994) 1.11
Lessons from patient-derived xenografts for better in vitro modeling of human cancer. Adv Drug Deliv Rev (2014) 1.10
Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun (2000) 1.10
Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res (2012) 1.08
Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer. Sci Rep (2015) 1.06
Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Oncogene (2002) 1.06
MMP-1 expression has an independent prognostic value in breast cancer. BMC Cancer (2011) 1.04
Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology (2013) 1.04
Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models. PLoS One (2013) 1.04
Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells. BMC Cancer (2014) 1.01
Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci (2009) 1.01
Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression. Cancer Lett (2015) 0.99
Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res (2011) 0.99
FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway. Oncotarget (2015) 0.98
Hedgehog signaling in myofibroblasts directly promotes prostate tumor cell growth. Integr Biol (Camb) (2012) 0.97
Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure. BMC Cancer (2015) 0.96
Microscale functional cytomics for studying hematologic cancers. Blood (2012) 0.95
Breast cancer cell-derived matrix supports vascular morphogenesis. Am J Physiol Cell Physiol (2012) 0.94
Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling. Am J Pathol (2013) 0.92
Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures. J Cell Physiol (2011) 0.92
FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells. PLoS One (2013) 0.89
Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo. Breast Cancer Res (2012) 0.89
The effect of cell subset isolation method on gene expression in leukocytes. Cytometry A (2013) 0.88
Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment. Semin Cancer Biol (2015) 0.87
Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity. Integr Biol (Camb) (2013) 0.85
Collagen-based co-culture for invasive study on cancer cells-fibroblasts interaction. Biochem Biophys Res Commun (2006) 0.85
Effect of homotypic and heterotypic interaction in 3D on the E-selectin mediated adhesive properties of breast cancer cell lines. Biomaterials (2012) 0.84
Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis. Integr Biol (Camb) (2014) 0.84
The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol (1998) 0.84
An in vitro model of the tumor-lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. Integr Biol (Camb) (2015) 0.84
A fine balance between CCNL1 and TIMP1 contributes to the development of breast cancer cells. Biochem Biophys Res Commun (2011) 0.83
Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res (2015) 0.83
VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin. Cancer Lett (2016) 0.82
New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells. J Cell Physiol (2011) 0.82
BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells. Cell Oncol (Dordr) (2014) 0.82
Human adipocytes stimulate invasion of breast cancer MCF-7 cells by secreting IGFBP-2. PLoS One (2015) 0.81
Streamlining gene expression analysis: integration of co-culture and mRNA purification. Integr Biol (Camb) (2014) 0.81
An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer. Breast Cancer Res (2015) 0.81
Hypoxia Affects the Structure of Breast Cancer Cell-Derived Matrix to Support Angiogenic Responses of Endothelial Cells. J Carcinog Mutagen (2013) 0.79
Lung epithelial cells induce both phenotype alteration and senescence in breast cancer cells. PLoS One (2015) 0.79
A microengineered pathophysiological model of early-stage breast cancer. Lab Chip (2015) 0.79
Matrix metalloproteinase-9 as a potential tumor marker in breast cancer. J Environ Pathol Toxicol Oncol (2013) 0.78
Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System. Biomed Res Int (2015) 0.76
Progress towards understanding heterotypic interactions in multi-culture models of breast cancer. Integr Biol (Camb) (2016) 0.76